NFA
WST icon

Nationwide Fund Advisors’s West Pharmaceutical WST Stock Holding History

Nationwide Fund Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-138,549
Closed -$13.3M – 2130
2017
Q3 		$13.3M Sell
138,549
-17,106
-11% -$1.55M 0.05% 487
2017
Q2 		$14.7M Buy
155,655
+6,533
+4% +$601K 0.06% 458
2017
Q1 		$12.2M Sell
149,122
-96,579
-39% -$8.08M 0.05% 552
2016
Q4 		$20.8M Sell
245,701
-13,630
-5% -$1.07M 0.09% 288
2016
Q3 		$19.3M Buy
259,331
+66,990
+35% +$5.32M 0.08% 305
2016
Q2 		$14.6M Sell
192,341
-42,243
-18% -$3.07M 0.06% 423
2016
Q1 		$16.3M Buy
234,584
+3,896
+2% +$234K 0.07% 369
2015
Q4 		$13.9M Sell
230,688
-45,751
-17% -$2.75M 0.06% 426
2015
Q3 		$15M Buy
276,439
+114,606
+71% +$6.68M 0.07% 359
2015
Q2 		$9.4M Sell
161,833
-11,330
-7% -$632K 0.04% 589
2015
Q1 		$10.4M Sell
173,163
-15,016
-8% -$800K 0.04% 568
2014
Q4 		$10M Sell
188,179
-9,433
-5% -$472K 0.04% 552
2014
Q3 		$8.85M Sell
197,612
-28,091
-12% -$1.19M 0.04% 623
2014
Q2 		$9.52M Buy
225,703
+12,054
+6% +$516K 0.04% 599
2014
Q1 		$9.41M Buy
213,649
+9,350
+5% +$440K 0.04% 531
2013
Q4 		$10M Buy
204,299
+23,861
+13% +$1.12M 0.04% 570
2013
Q3 		$7.42M Buy
180,438
+44,694
+33% +$1.71M 0.03% 686
2013
Q2 		$4.77M Buy
+135,744
New +$4.47M 0.03% 832

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Nationwide Fund Advisors's WST Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of West Pharmaceutical (WST) in Q4 2017, closing a stake of 138,549 shares — an estimated $13.3M sold.

Nationwide Fund Advisors first reported a position in WST in Q2 2013 and held it in 18 quarters. The position peaked at $20.8M in Q4 2016. 338 funds tracked by Wall St. Rank hold WST as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining West Pharmaceutical position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 138,549 West Pharmaceutical shares in Q4 2017, an estimated $13.3M.
  • Nationwide Fund Advisors first reported a position in West Pharmaceutical in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's West Pharmaceutical position peaked at $20.8M in Q4 2016.
  • 338 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.